InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: None

Friday, 12/02/2016 3:48:05 PM

Friday, December 02, 2016 3:48:05 PM

Post# of 16695
The Atlantic - Excerpts

With the encouragement of the research community and the pharmaceutical industry, both sought legislation that would make it easier to find life-saving cures by cutting barriers that hold up clinical trials and the approval of new drugs and devices those studies can lead to.

“Those changes will last for decades after the money is spent,” DeGette said in an interview. “It’s really not just bringing devices and drugs to market more quickly, but it’s also being able to expedite the basic research behind the way we’re developing these devices.”

The White House gave the final compromise its strong support, saying the legislation “offers advances in health that far outweigh” its concerns about the funding of the bill, which came partly from selling off oil from the Strategic Petroleum Reserve.

www.theatlantic.com/politics/archive/2016/12/cures-act-compromise-elizabeth-warren/509228/

The 21st Century Cures Act will be a done deal come next week. I emailed management (Nov 30) for a response to new legislation, and it's potential impact on clinical trials and costs moving forward. I encourage others to do so as well. Meanwhile, I'm looking forward to the Monthly Report (Dec 5 2016).

T.G.I.F.

/////AMG